3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
2
Phase EARLY_PHASE1
1
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Renal Insufficiency
1
Osteosarcoma
1
Lymphoma
1
Leukemia
1
Interventions
Cyclophosphamide
14
Gemcitabine
6
Filgrastim
6
fludarabine
5
Methotrexate
5
Leucovorin
5
Granulocyte Colony-Stimulating Factor
5
Zoledronic Acid
4
Temozolomide
4
Mesna
4
Irinotecan
4
Ifosfamide
4
Etoposide
4
Cisplatin
4
Carboplatin
4
pembrolizumab
3
fludarabine phosphate
3
Doxorubicin
3
Biopsy
3
tanespimycin
2
poly ICLC
2
pegfilgrastim
2
lorukafusp alfa
2
liposomal doxorubicin
2
dinutuximab
2
cabozantinib
2
belinostat
2
Topotecan
2
Thalidomide
2
Specimen Handling
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
Osteosarcoma
×
glucarpidase
×
Clear all
NCT00634504
2022-06-06
LVPK
BTG International Inc.
Phase 1
Completed
20 enrolled
9 charts